Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/1991
09/02/1991CA2037325A1 Thrombin composition for oral administration
08/1991
08/28/1991EP0443875A2 Vectors and compounds for expression of zymogen forms of human protein C
08/28/1991EP0443874A2 Vectors and compounds for expression of glycosylation mutants of human protein C
08/28/1991EP0443724A1 Viral-safe purified human thrombin
08/28/1991EP0443598A2 Peptides inhibiting the blood coagulation, their process of preparation and their use
08/28/1991EP0443429A1 Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
08/28/1991EP0443404A1 Peptide fragments and analogs of thrombospondin
08/28/1991EP0408749A4 Derivatives of 3,18-dihydroxy-9,13-epoxylabdane, method of obtaining them and a hemostatic pharmaceutical preparation based thereon
08/27/1991US5043456 6-oxa and thiabicyclo [3.1.0.] compounds
08/27/1991US5043451 Bicyclo (2.2.1.) hept-exo-2-yl and bicyclo (2.2.2.) oct-endo-2-yl compounds
08/27/1991US5043429 Anticoagulant polypeptide
08/27/1991US5043425 Anticoagulants
08/27/1991US5043347 Indanes and analgesic compositions and methods thereof
08/27/1991US5043341 N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
08/27/1991US5043335 Enzyme inhibitors; cardiovascular and central nervous system disorders
08/27/1991US5043156 Method of treating infectious diseases with granulocyte colony-stimulating factor
08/27/1991CA2035265A1 Process for preparing ¬1s-¬1.alpha.,2.alpha.(z), 3.alpha.,4.alpha.||-7-¬3-¬¬¬¬(1-oxoheptyl)-amino|-acetyl|amino|methyl|-
08/27/1991CA1288045C Apparatus and process for oxygenation of liquid state dissolved oxygen-carrying formulation
08/24/1991CA2036915A1 Vectors and compounds for expression of zymogen forms of human protein c
08/23/1991CA2036815A1 Peptides which inhibit blood coagulation, processes for the preparation thereof and the use thereof
08/23/1991CA2036774A1 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptorantagonist or a
08/23/1991CA2036093A1 Peptide fragments and analogs of thrombospondin
08/22/1991WO1991012253A1 Tetralin and chroman derivatives useful in the treatment of asthma, arthritis, and related diseases
08/22/1991WO1991012235A1 Allosteric hemoglobin modifiers
08/22/1991WO1991009951A3 Recombinant protein c with truncated light chain
08/21/1991EP0442724A2 Modified hIL-6
08/21/1991EP0442423A1 Use of buspirone in sleep apneas
08/21/1991EP0442348A2 Imidazole compounds, process for preparation, medicaments based on these compounds and some intermediates
08/21/1991CN1053919A Imidazole compounds, their preparing process and pharmaceutical based of compounds and some intermediums
08/20/1991US5041635 5(Z)-7-(endo-3-benzenesulfonamidobicyclo[2.2.1]hept-exo-2-yl)-5-heptenoic acid, sodium salt
08/20/1991US5041451 Analgesics, hypotensive agents
08/20/1991US5041444 Hypoglycemic agents; anticoagulants
08/17/1991WO1991012017A1 Heparin neutralization with platelet factor 4
08/17/1991CA2075957A1 Heparin neutralization with platelet factor 4
08/14/1991WO1991011909A1 Triazole angiotensin ii antagonists incorporating a substituted benzyl element
08/14/1991EP0441515A1 Tetralin and chroman derivatives in the treatment of asthma, arthritis and related diseases
08/14/1991EP0441274A2 Process for the purification of lipocortins
08/14/1991EP0440763A1 t-PA MUTANT GK1L.
08/14/1991EP0440731A1 2-aminocarboxylic acid derivatives, their manufacture and use as drugs
08/14/1991EP0440709A1 Thrombolytic agents with modified kringle domains.
08/14/1991DE4004061A1 New imidazole-sulphonamide and sulphonic acid derivs. derivs. - used to treat e.g. micro-circulation disorders, inflammatory muscle conditions and thrombosis and to inhibit cancer metastasis
08/14/1991CA2075639A1 Triazole angiotensin ii antagonists incorporating a substituted benzyl element
08/13/1991US5039805 Novel benzoic and phenylacetic acid derivatives
08/13/1991US5039670 Anticoagulants, antiasthma, antiallergens
08/13/1991US5039529 Novel heparin derivatives
08/13/1991CA2036055A1 Buspirone: use in sleep apneas
08/13/1991CA1287629C Thiolactam-n-acetic acid derivatives, their production and use
08/11/1991CA2035988A1 Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediaes
08/09/1991WO1991012237A1 Benzenesulfonamide derivative
08/09/1991CA2050591A1 Benzenesulfonamide derivatives
08/09/1991CA2035927A1 Process for purifying lipocortins
08/08/1991WO1991011200A1 Improved cyclodextrin based erythropoietin formulation
08/08/1991CA2035626A1 Tetralin and chroman derivatives in the treatment of asthma, arthritis and related diseases
08/07/1991WO1991012526A1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
08/07/1991EP0440311A1 A process for the production of alpha-human atrial natriuretic polypeptide
08/07/1991EP0245357B1 Angiostatic steroids
08/07/1991CN1013444B Process for the preparation of a novel class of hypoglycemic agents
08/07/1991CA2075491A1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
08/06/1991US5037990 Antagonist, antagonism, bronchodilator; antiischemic agents, treatment of cardiovascular disorder, kidney dialysis; and antiulcer agent
08/06/1991US5037957 Cysteine proteinase inhibitor
08/06/1991US5037827 Glycerin derivative and its pharmacological use
08/06/1991US5037808 Indolyl platelet-aggregation inhibitors
08/03/1991WO1991011197A1 New method for treating immunodeficiency or neutropenia
08/03/1991CA2075191A1 Method for treating immunodeficiency or neutropenia
08/01/1991DE4001451A1 Stabile injizierbare loesungen von faktor viii und faktor ix Stable injectable loesungen of factor viii and ix factor
07/1991
07/31/1991EP0439442A2 Factor x-laci hybrid protein
07/31/1991EP0439265A1 Novel 1,3-dicarbonyl compounds and their use
07/31/1991EP0439156A1 Process for the production of thrombin and high purity thrombin preparation thereby obtained
07/30/1991WO1991011514A1 Anticoagulant proteins
07/30/1991US5036104 Enzyme inhibitors
07/30/1991CA1286988C Use of ghl-cu as a wound-healing and anti-inflammatory agent
07/25/1991WO1991010439A1 Stable injectible solutions for factor viii and factor ix
07/25/1991CA2034826A1 Process for the production of thrombin and high purity thrombin preparations thereby obtained
07/24/1991EP0437790A2 Antithrombotic compounds
07/24/1991EP0437505A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells
07/24/1991CN1053265A Human c3b/c4b receptor (cr1)
07/23/1991US5034414 Liquid emulsion for transfusion
07/23/1991US5034381 2-(substituted amino) adenosines as antihypertensives
07/23/1991CA1286844C Pharmaceutical compositions
07/23/1991CA1286679C 7-oxabicycloheptane substituted diacid diamide prostaglandin analogs
07/17/1991EP0437367A2 Compositions and methods for inhibiting osteoclast cellular adhesion to bone
07/17/1991EP0436612A1 Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer
07/17/1991CN1053064A Process for preparing heterocyclic derivatives
07/16/1991US5032614 Vasodilator
07/16/1991US5032507 Potentiation of erythropoiesis
07/16/1991US5032396 Interleukin-7
07/16/1991CA1286286C Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use
07/13/1991WO1991010662A1 2-substituted 4,5-diphenyl-imidazoles
07/13/1991CA2073443A1 2-substituted 4,5-diphenyl-imidazoles
07/12/1991CA2033928A1 Compositions and methods for inhibiting osteoclast cellular adhesion to bone
07/11/1991WO1991009951A2 Recombinant protein c with truncated light chain
07/11/1991WO1991009641A1 Fibrin sealant delivery method
07/11/1991WO1991009615A1 Polyhemoglobin stabilized by purine derivatives and glutathione
07/11/1991WO1991009601A1 Use of inositolphosphates for preparing medicament
07/09/1991WO1991010684A1 Oxidized variants of gm-csf
07/09/1991US5030644 Imidazole compounds and their use as transglutaminase inhibitors
07/09/1991US5030630 Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone
07/09/1991US5030215 Preparation of fibrinogen/factor XIII precipitate
07/09/1991CA2072587A1 Oxidized variants of gm-csf
07/09/1991CA1285953C 7-oxabicycloheptane substituted aminoalkyl amide prostaglandin analogs
1 ... 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 ... 671